A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

With new treatments and maybe even a vaccine on the horizon, 2025 could be an important year for improving the lives of ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

The latest recommendations are presented for the treatment and prevention of HIV, including new antiretroviral therapies and long-acting injectable options.

The Chang'e-6 spacecraft drilled beneath the Moon's surface and returned with 2kg of rock and soil samples. These materials ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...